Stephen A. Hancock
GlaxoSmithKline
2 Papers
8 Citations
Stephen A. Hancock is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Artesunate & Chlorproguanil/dapsone/artesunate. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
A New Approach to Accelerated Drug-Excipient Compatibility Testing
Jonathan L. Sims,Judith A. Carreira,Daniel J. Carrier,Simon R. Crabtree,Lynne Easton,Stephen A. Hancock,Carol E. Simcox +6 more
TL;DR: The technique developed was able to mimic the 1-month's accelerated degradation in just 1 hr and was suitable for automated analysis, capable of multisample stressing, and ideal for use in drug-excipient compatibility screening.
49
Formation and identification of a degradant in chlorproguanil-dapsone-artesunate (Dacart™) tablets.
Ben Bardsley,Samantha J. Barry,Malgorzata A. Drozdz,Stephen A. Hancock,George Okafo,Magdalena M. Szafran +5 more
TL;DR: The formation of this degradant demonstrates a potential stability risk for future combination therapies incorporating artesunate and is particularly pertinent to products of this type given the climatic conditions which prevail in countries where such therapies are likely to be employed.
8